NASDAQ:AGTC
Delisted
Applied Genetic Technologies Corporation Stock News
$0.397
+0 (+0%)
At Close: Feb 28, 2023
uniQure (QURE) Receives a Rating Update from a Top Analyst
03:26pm, Tuesday, 03'rd Mar 2020
Chardan Capital analyst
Gbola Amusa
reiterated a
Buy
rating on uniQure (
QURE
–
Research Report
) today and set a price target of
$105.00
. The company’s shares closed last Monday at $56.50.
Accor
Analysts Are Bullish on Top Healthcare Stocks: Sorrento Therapeutics (SRNE), Ligand Pharma (LGND)
12:23pm, Monday, 02'nd Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sorrento Therapeutics (SRNE) and Ligand Pharma (LGND) with
Analysts Are Bullish on Top Healthcare Stocks: Sorrento Therapeutics (SRNE), Ligand Pharma (LGND)
12:23pm, Monday, 02'nd Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sorrento Therapeutics
Analysts’ Top Healthcare Picks: Rigel (RIGL), Concert Pharma (CNCE)
12:15pm, Friday, 28'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rigel (RIGL
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viking Therapeutics (VKTX), Cyclacel Pharmaceuticals (CYCC)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viking Therapeutics (
VKTX
–
Research Report
), Cyclacel Pharmaceuticals (
CYCC
–
Research Report
)
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Puma Biotechnology (PBYI)
04:01pm, Wednesday, 26'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Puma Biotechnology (PBYI) with
Analysts Offer Insights on Healthcare Companies: Cytokinetics (NASDAQ: CYTK) and Puma Biotechnology (NASDAQ: PBYI)
04:00pm, Wednesday, 26'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK
Kura Oncology (KURA) Received its Third Buy in a Row
12:21pm, Wednesday, 26'th Feb 2020
After Cowen & Co. and Oppenheimer gave Kura Oncology (NASDAQ: KURA) a Buy rating last month, the company received another Buy, this time from H.C.
Kura Oncology (KURA) Received its Third Buy in a Row
12:21pm, Wednesday, 26'th Feb 2020
After Cowen & Co. and Oppenheimer gave Kura Oncology (NASDAQ:
KURA
) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst
Joseph Pantginis
reiterated a
Bu
Iovance Biotherapeutics (IOVA) Receives a Buy from H.C. Wainwright
12:21pm, Wednesday, 26'th Feb 2020
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Iovance Biotherapeutics (IOVA) today and set a price target of $36.00. The company's
Iovance Biotherapeutics (IOVA) Receives a Buy from H.C. Wainwright
12:21pm, Wednesday, 26'th Feb 2020
H.C. Wainwright analyst
Joseph Pantginis
reiterated a
Buy
rating on Iovance Biotherapeutics (
IOVA
–
Research Report
) today and set a price target of
$36.00
. The company’s shares closed last Mon
Global Gene Therapy Market Projected to Grow with a CAGR of 34.8% During the Forecast Period, 2019-2026 - ResearchAndMarkets.com
03:48pm, Tuesday, 25'th Feb 2020
The "Gene Therapy Market by Vector Type, Gene Type and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
Reviewing Applied Genetic Technologies (NASDAQ:AGTC) & Halozyme Therapeutics (NASDAQ:HALO)
07:08am, Tuesday, 25'th Feb 2020
Applied Genetic Technologies (NASDAQ:AGTC) and Halozyme Therapeutics (NASDAQ:HALO) are both medical companies, but which is the better investment? We will compare the two companies based on the streng
